MEDP
Medpace Holdings, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Medpace Holdings, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
No other changes.
No other changes.
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Annual filing, covered
10-K parsed · Feb 10 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Feb 10 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Medpace Holdings, Inc.
663.52
+15.38 · +2.37%
post 663.49 0.00%
Same SIC code · 6
Same SEC industry code: Iqvia Holdings Inc., Incyte Corp, Charles River Laboratories International, Inc. and 3 more; no measured co-movers for Medpace Holdings, Inc..
Same SIC code · 6
Same SEC industry code: Iqvia Holdings Inc., Incyte Corp, Charles River Laboratories International, Inc. and 3 more; no measured co-movers for Medpace Holdings, Inc..
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $1.3B | 10.06% | +1.13% |
| T. Rowe Price | $1.1B | 8.33% | +614.90% |
| AQR | $677.3M | 5.15% | −5.53% |
| Vanguard Portfolioindex-like | $600.2M | 4.56% | +1.04% |
| Vanguardindex-like | $543.8M | 4.13% | +1.56% |
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $1.3B | 10.06% | +1.13% |
| T. Rowe Price | $1.1B | 8.33% | +614.90% |
| AQR | $677.3M | 5.15% | −5.53% |
| Vanguard Portfolioindex-like | $600.2M | 4.56% | +1.04% |
| Vanguardindex-like | $543.8M | 4.13% | +1.56% |
Bull3
Bear2
Expected move
No implied move.
Linked news